AGIOS PHARMACEUTICALS, INC.: operating_income
| Value | {"amount": -22995000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-12-31 |
| Status | current |
| Entity | AGIOS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:11:23.643608+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e80c0d4c-8b22-4b53-88b5-75596059bda9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-14-104521Retrieved: 2026-08-19T14:11:23.643608+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001439222/operating-income/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e80c0d4c-8b22-4b53-88b5-75596059bda9
History
- no predecessors — first report